Table 5 Multivariate associations of variables with immune status among ART-naïve study participants in Addis Ababa, Ethiopia
Variables | CD4 < 200 and/or stages III/IV, AOR (95% CI) | CD4 < 350 and/or stages III/IV, AOR (95% CI) | CD4 < 500 and/or stages III/IV, AOR (95% CI) |
|---|---|---|---|
Gender | |||
Male | 1.00 | 1.00 | 1.00 |
Female | 0.58(0.36–0.95) | 0.60(0.36–0.99) | 0.38(0.19–0.73) |
HIV RNA load (copies/mL) | |||
< 10,000 | 1.00 | 1.00 | 1.00 |
≥ 10,000 | 3.89(2.34–6.46) | 4.09(2.80–6.00) | 4.49(2.69–7.49) |
Hemoglobin conc. (g/dL) | |||
Non-anemic | 1.00 | 1.00 | 1.00 |
Anemic | 2.39(1.28–4.46) | 1.73(0.86–3.56)* | 1.67(0.65–4.28)* |
Total cholesterol conc. (mg/dL) | |||
> 200 | 1.00 | 1.00 | 1.00 |
≤ 200 | 2.14(1.01–4.59) | 1.53(0.90–2.54)* | 1.38(0.75–2.56)* |